Researchers at the University of New South Wales in Australia have developed a novel approach to converting adult fat and bone cells into induced multipotent stem (iMS) cells. The process is completed using a compound known as 5-Azacytidine (AZA) in conjunction with growth factor-AB (PDGF-AB). This is an important advance over embryonic stem cell research because using viruses to transform somatic cells into tissue specific stem cells “is clinically unacceptable.”

Click here to read the research paper published in PNAS, Proceedings of the National Academy of Sciences of the United States of America.